Skip to main content

Table 4 OM severity in patients under chemotherapy with head and neck radiotherapy

From: Effects of nanomicelle curcumin capsules on prevention and treatment of oral mucosits in patients under chemotherapy with or without head and neck radiotherapy: a randomized clinical trial

 

WHO oral mucositis grade mean in study group

WHO oral mucositis grade mean in control group

Significance

(T-test statistic)

NRS mean in study group

NRS mean in control group

Significance

(T-test statistic)

Participants

7

6

 

7

6

 

Base line

0

0

–

0

0

–

Week 1

1.00

1.00

–

2.28 ± 0.75

1.83 ± 1.16

0.309 (0.88)

Week 2

1.71 ± 0.48

1.83 ± 0.40

0.646 (0.119)

4.14 ± 0.89

3.83 ± 1.16

0.113 (0.67)

Week 4

2.14 ± 0.37

2.83 ± 0.40

0.009 (0.690)

5.00 ± 1.00

5.33 ± 1.21

0.805 (0.15)

Week 7

2.14 ± 0.37

3.00 ± 0.63

0.012 (0.857)

5.28 ± 0.75

6.16 ± 2.13

0.238 (0.52)